Susan Zolla-Pazner

发表

CCR5/CXCR4 discriminating sites in the HIV-1 gp120 core

Timothy Cardozo, Arthur Nadas, Alpna Agarwal, 2011, BCB '11.

Structure/function relationships relevant to the V3 loop of HIV-1 gp120

Timothy Cardozo, Tetsuya Kimura, Susan Zolla-Pazner, 2005 .

Effective neutralization and neutralization epitope masking signatures for four anti-V3 mAbs

Alpna Agarwal, Susan Zolla-Pazner, James Swetnam, 2010, BCB '10.

Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection

Gary J. Nabel, Youyi Fong, Peter B. Gilbert, 2014, PloS one.

Truncation of the Cytoplasmic Domain Induces Exposure of Conserved Regions in the Ectodomain of Human Immunodeficiency Virus Type 1 Envelope Protein

Susan Zolla-Pazner, R. Doms, J. Hoxie, 2002, Journal of Virology.

Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies

Renate Kunert, Bette Korber, Christos J. Petropoulos, 2004, Journal of Virology.

Genetic and biological properties of HIV type 1 isolates prevalent in villagers of the Cameroon equatorial rain forests and grass fields: further evidence of broad HIV type 1 genetic diversity.

Susan Zolla-Pazner, S. Zolla-Pazner, Liying Ma, 2003, AIDS research and human retroviruses.

Identifying epitopes of HIV-1 that induce protective antibodies

Susan Zolla-Pazner, S. Zolla-Pazner, 2004, Nature Reviews Immunology.

Alternative conformations of HIV-1 V3 loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity.

Michal Sharon, Matthias Görlach, Rina Levy, 2003, Structure.

Immune-correlates analysis of an HIV-1 vaccine efficacy trial.

Guido Ferrari, Youyi Fong, Jaranit Kaewkungwal, 2012, The New England journal of medicine.

Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

Raphael Gottardo, Hongmei Gao, Bette T. Korber, 2013, Journal of Virology.

Structure–function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design

Timothy Cardozo, Susan Zolla-Pazner, S. Zolla-Pazner, 2010, Nature Reviews Immunology.

Crystal structure , conformational fixation , and entry-related interactions of mature ligand-free HIV-1 Env

Young Do Kwon, Tongqing Zhou, Baoshan Zhang, 2016 .

Synergistic Neutralization of Simian-Human Immunodeficiency Virus SHIV-vpu+ by Triple and Quadruple Combinations of Human Monoclonal Antibodies and High-Titer Anti-Human Immunodeficiency Virus Type 1 Immunoglobulins

Susan Zolla-Pazner, Hermann Katinger, Joseph Sodroski, 1998, Journal of Virology.

Conserved structural elements in the V3 crown of HIV-1 gp120

Timothy Cardozo, Maxim Totrov, Susan Zolla-Pazner, 2010, Nature Structural &Molecular Biology.

Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades

Abraham Pinter, Susan Zolla-Pazner, S. Zolla-Pazner, 2002, Journal of Virology.

Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.

David C Montefiori, Susan Zolla-Pazner, Nelson L Michael, 2008, Virology.

Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial

Raphael Gottardo, S. Gnanakaran, Hongmei Gao, 2013, PloS one.

Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D.

Robyn L Stanfield, Ian A Wilson, Susan Zolla-Pazner, 2004, Structure.

A Global Neutralization Resistance Phenotype of Human Immunodeficiency Virus Type 1 Is Determined by Distinct Mechanisms Mediating Enhanced Infectivity and Conformational Change of the Envelope Complex

Susan Zolla-Pazner, S. Zolla-Pazner, G. Quinnan,, 2000, Journal of Virology.

A Variable Region 3 (V3) Mutation Determines a Global Neutralization Phenotype and CD4-Independent Infectivity of a Human Immunodeficiency Virus Type 1 Envelope Associated with a Broadly Cross-Reactive, Primary Virus-Neutralizing Antibody Response

Susan Zolla-Pazner, Peter Bouma, J. Margolick, 2002, Journal of Virology.

Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals.

Ashutosh Biswas, Susan Zolla-Pazner, Michael S Seaman, 2013, Virology.

Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection

S. Munir Alam, Susan Zolla-Pazner, Barton F. Haynes, 2007, Journal of Virology.

Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination

Gary J. Nabel, Guido Ferrari, Youyi Fong, 2014, Science Translational Medicine.

Human Immunodeficiency Virus (HIV) Envelope Binds to CXCR4 Independently of CD4, and Binding Can Be Enhanced by Interaction with Soluble CD4 or by HIV Envelope Deglycosylation

Susan Zolla-Pazner, J. Hoxie, S. Zolla-Pazner, 1998, Journal of Virology.

Analysis of HLA A*02 Association with Vaccine Efficacy in the RV144 HIV-1 Vaccine Trial

Raphael Gottardo, Tomer Hertz, John Sidney, 2014, Journal of Virology.

Crystal Structure of Human Antibody 2909 Reveals Conserved Features of Quaternary Structure-Specific Antibodies That Potently Neutralize HIV-1

Baoshan Zhang, Peter D. Kwong, John R. Mascola, 2010, Journal of Virology.

Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2.

Guido Ferrari, Jaranit Kaewkungwal, Xiaozhi Lu, 2013, Immunity.